Japan’s AGC has announced plans for a new, 7,500 m2 building at the site of its AGC Pharma Chemicals Europe CDMO operation in Spain. Costing about $100 million, this is scheduled to begin operation in 1H 2024 and will add 30% to the site’s capacity. This comes on top of a 30% increase in capacity announced in April 2020.
AGC has announced plans to expand its CDMO subsidiary, AGC Pharma Chemicals Europe. As well as adding 30% to the capacity of its production facilities by May 2022, this will see the addition of a new micronisation facility and a new R&D facility, which is due to begin operation in March 2021. The plant, near Barcelona, was originally known as Malgrat Pharma Chemicals.
